Talk:Tedatioxetine
![]() | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tedatioxetine.
|
Citation check
[edit]I added a citation check template since the article cites a press release from March 2010 saying that the drug is ready for Phase III trials, while the Lundbeck site gives LU AA24530 as being in Phase II (http://investor.lundbeck.com/pipeline.cfm) and the Takeda site states that the drug is in Phase I but "to be prepared for P-III in the US" (http://www.takeda.com/pdf/usr/default/12_3_45015_2.pdf). I don't know if the 2010 press release gave inaccurate information or if the drug for some reason has been moved back to Phase II (or Phase I?) trials, but it would be helpful if someone with more knowledge could shed some light on this. I have tried to dig around with my limited insight into the pharmaceutical industry but have found nothing. 83.226.206.82 (talk) 09:23, 20 April 2012 (UTC)
Did this ever get addressed? Grammarpolicealpha (talk) 10:58, 4 April 2020 (UTC)
Last line entry
[edit]The last line of this article about "Sino Patent" is clunky. I want to clean it up, but I'm not even sure what the line is supposed to say. Who added it? Grammarpolicealpha (talk) 11:00, 4 April 2020 (UTC)